Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
948,570
-
Share change
-
+358,757
-
Total reported value
-
$4,107,472
-
Price per share
-
$4.37
-
Number of holders
-
20
-
Value change
-
+$2,064,199
-
Number of buys
-
9
-
Number of sells
-
3
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q2 2023
As of 30 Jun 2023,
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
948,570 shares.
The largest 10 holders included
CITIGROUP INC, Corbin Capital Partners, L.P., Atalaya Capital Management LP, MORGAN STANLEY, JPMORGAN CHASE & CO, ProVise Management Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, Grey Street Capital, LLC, LEVIN CAPITAL STRATEGIES, L.P., and Circle Wealth Management, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.